Results 201 to 210 of about 956,535 (302)

Correction: Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis

Frontiers in Immunology
Clara Sánchez-Menéndez, Clara Sánchez-Menéndez, Clara Sánchez-Menéndez, Alejandro Zurdo, Magdalena Corona, Elena Mateos de la Morenas, Elena Mateos de la Morenas, Sara Rodríguez-Mora, Sara Rodríguez-Mora, Guiomar Casado, Guiomar Casado, Javier García-Pérez, Javier García-Pérez, Mayte Pérez-Olmeda, Mayte Pérez-Olmeda, Susana Domínguez, María Aránzazu Murciano-Antón, Javier López-Jiménez, Valentín García-Gutiérrez, Mayte Coiras, Mayte Coiras, Montserrat Torres, Montserrat Torres   +22 more
doaj   +1 more source

Within-Subtype HIV-1 Polymorphisms and Their Impacts on Intact Proviral DNA Assay (IPDA) for Viral Reservoir Quantification. [PDF]

Viruses
Arikatla MR, Mathad JS, Reddy K, Reddy N, Ndung'u T, Dupnik KM, Lee GQ.   +6 more
europepmc   +1 more source

The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV. [PDF]

Lancet HIV, 2020
Palma P, McManus M, Cotugno N, Rocca S, Rossi P, Luzuriaga K.   +5 more
europepmc   +1 more source

Microfluidic Molecular Diagnostic Chips: Functional Modules, Integration Strategies, and Emerging Applications

Small Methods, EarlyView.
This comprehensive review delivers an engineering‐centric analysis of microfluidic molecular diagnostic chips, breaking them down into foundational modules from fluid manipulation to bio‐sensing. Beyond chip design, it evaluates sample‐to‐answer integration strategies and commercial readiness levels.
Donghoon Koo, Egor Kokin, Sangyul Baik, Chanyong Park, Minji Kim, Jeongmin Kim, Ryungeun Song, Hosub Lim   +7 more
wiley   +1 more source

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir. [PDF]

Elife
van Paassen PM, Pasternak AO, Bolluyt DC, van Dort KA, van Nuenen AC, Maurer I, Boeser-Nunnink B, Buchholtz NVEJ, Mahmoudi T, Lungu C, van Crevel R, Rokx C, Symons J, Nijhuis M, van der Veen ALIP, Vogt L, Klouwens MJ, Prins JM, Kootstra NA, de Bree GJ.   +19 more
europepmc   +1 more source

Extremely low viral reservoir in treated chronically HIV-1-infected individuals. [PDF]

EBioMedicine, 2020
Gálvez C, Urrea V, Dalmau J, Jimenez M, Clotet B, Monceaux V, Huot N, Leal L, González-Soler V, González-Cao M, Müller-Trutwin M, Sáez-Cirión A, García F, Blanco J, Martinez-Picado J, Salgado M.   +15 more
europepmc   +1 more source

B Lymphocytes, but Not Dendritic Cells, Efficiently HIV-1 <i>Trans</i> Infect Naive CD4⁺ T Cells: Implications for the Viral Reservoir. [PDF]

mBio, 2021
Gerberick A, DeLucia DC, Piazza P, Alaoui-El-Azher M, Rinaldo CR, Sluis-Cremer N, Rappocciolo G.   +6 more
europepmc   +1 more source

Prevalence of HCMV, HHV‐6, and HSV‐1/2 in the semen of men attending infertility clinics and their association with semen parameters

UroPrecision, EarlyView.
Abstract Background Viral infections have been identified as potential disruptors of male reproductive health. This study aimed to investigate the prevalence of human cytomegalovirus (HCMV), human herpesvirus 6 (HHV‐6), and herpes simplex virus types 1 and 2 (HSV‐1/2) DNA in semen samples from fertile and infertile men within the potential impact of ...
Seyedeh Zahra Hashemi, Neda Pirbonyeh, Fahime Edalat, Narges Eslami, Saeed Tajik, Arash Letafati, Jamal Sarvari, Afagh Moattari   +7 more
wiley   +1 more source

Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus Macaques. [PDF]

Infect Dis Rep
Clain JA, Picard M, Rabezanahary H, André S, Boutrais S, Goma Matsetse E, Dewatines J, Dueymes Q, Thiboutot E, Racine G, Soundaramourty C, Mammano F, Corbeau P, Zghidi-Abouzid O, Estaquier J.   +14 more
europepmc   +1 more source

Safety of and serological response to a new canine distemper‐parvovirus combination vaccine in domestic ferrets

Veterinary Record, EarlyView.
Abstract Background Pet ferrets are typically vaccinated against distemper using a canine multivalent vaccine despite the lack of relevant safety or efficacy data. Here, we investigate the safety of a novel live canine parvovirus type 2c (CPV‐2c) vaccine strain and the efficacy of the live Onderstepoort canine distemper virus (CDV) vaccine strain used ...
Jacqueline Pearce, Léon Peeters, Ellen Versmissen, David Sutton, Ian Tarpey   +4 more
wiley   +1 more source